MABWELL BIOTECH
Mabwell Biotech is a Chinese innovative biopharmaceutical company based in Shanghai Zhangjiang Hi-Tech Park. Since its establishment in 2017, it has absorbed and newly established nine biopharmaceutical R&D and production enterprises. At present, the company focuses on the development and manufacturing of macromolecular drugs such as therapeutic monoclonal antibodies and long-acting recombinant proteins. There are more than thirty varieties of drugs at different stages of development covering tumor, autoimmunity, anti-infection and ophthalmic diseases. Among them, six of them have entered the clinical stage, and three of them are in Phase III clinical trials.
MABWELL BIOTECH
Industry:
Biopharma Biotechnology Life Science
Founded:
2017-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.mabwell.com
Total Employee:
11+
Status:
Active
Total Funding:
278.5 M USD
Similar Organizations
5Lmeet
5Lmeet is a Chinese co-working space company.
AVATAMED
Biotechnology, Biopharmaceutical
Sio Gene Therapies
Sio Gene Therapies is a clinical-stage biopharmaceutical company.
BiondVax
BiondVax is an innovative biopharmaceutical company.
Chime Biologics
Chime Biologics is a biopharmaceutical development and manufacturing company.
CMAB BioPharm
CMAB BioPharm is a Biopharmaceutical Service Firm.
EOC Pharma Group
EOC Pharma is an integrated biopharmaceutical company.
EpimAb Biotherapeutics
EpimAb Biotherapeutics is a privately owned biopharmaceutical R&D company.
Excell Biology
Excell Biology is a supplier of raw materials to the biopharmaceutical and precision medicine industries.
Frontier Biotechnologies
Frontier Biotechnologies is a commercial-stage bio-pharmaceutical company.
Future High-tech
Future High-tech is a shanghai based Industrial & Manufacturing company.
GenomiCare Biotechnology
GenomiCare Biotechnology is a Chinese precision cancer medicine service company
Great Bay Bio
Great Bay Bio is a high-tech company developing blue ocean biopharmaceuticals with a digital CMC platform.
Immunophage Biotech
Immunophage Biotech is a Nanjing-based pharmaceutic company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Majecules
Research as a service, Saas, Education
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
OPM Biosciences
Biotech company based in Shanghai.
Pulse language (Maizhiyu)
Pulse language is an Internet Chinese medicine intelligent equipment company
Samsung Bioepis
Samsung Bioepis is a biopharmaceutical company.
Shandong Sinobioway
Sinobioway Bio-medicine Co is a research-driven biopharmaceutical company.
Suhua
Suhua is an innovative synthetic biotechnology skin care brand.
Swixx Biopharma
Swixx Biopharma fully represents biopharma companies in the CEE.
VivaVision Biotech
VivaVision Biotech is a clinical-stage R&D biopharmaceutical company that is developing novel medicines to treat topical diseases.
YS Biopharma
YS Biopharma is a global, fully integrated bio-pharmaceutical company.
Yudao Bio
Yudo Bio is a provider of biopharmaceutical products
ZSHK Laboratories
ZSHK Lab is a company located in Wan Chai, Hong Kong Island, Hong Kong.
Current Employees Featured
Founder
Investors List
Sincere Capital
Sincere Capital investment in Series A - Mabwell Biotech
Founder H Fund
Founder H Fund investment in Series A - Mabwell Biotech
Shiyu Capital
Shiyu Capital investment in Series A - Mabwell Biotech
Haitong Leading Capital Management
Haitong Leading Capital Management investment in Series A - Mabwell Biotech
Oriental Fortune Capital
Oriental Fortune Capital investment in Series A - Mabwell Biotech
Loyal Valley Capital
Loyal Valley Capital investment in Series A - Mabwell Biotech
Huajin Capital
Huajin Capital investment in Series A - Mabwell Biotech
Huarong Rongde Asset Management
Huarong Rongde Asset Management investment in Series A - Mabwell Biotech
Winfast Holding
Winfast Holding investment in Series A - Mabwell Biotech
Official Site Inspections
http://www.mabwell.com
- Host name: 47.101.141.235
- IP address: 47.101.141.235
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Mabwell Biotech"
Mabwell - Explore Life, Benefit Health
Mabwell (SSE: 688062) is an innovation-driven biopharmaceutical company with an entire industry chain of R&D, manufacturing, and commercialization. Consistent with our commitment …See details»
迈威生物 - 探索生命，惠及健康
迈威生物是一家全产业链布局的创新型生物制药公司，始终秉承“让创新从梦想变成现实”的愿景，践行“探索生命，惠及健康”的使命，通过源头创新，为患者提供疗效更好、可及性更强的生 …See details»
Mabwell - LinkedIn
Mabwell | 1,683 followers on LinkedIn. Explore Life, Benefit Health | Mabwell (688062.SH), an innovation-driven biopharmaceutical company, has the entire industrial chain of R&D, manufacturing ...See details»
Mabwell Biotech - Crunchbase Company Profile & Funding
Organization. Mabwell Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Mabwell Biotech is a Chinese …See details»
Mabwell Therapeutics, Inc.
Jan 20, 2023 Mabwell Announces the NMPA approval of 9MW3011 (FIC) for IND Read more . Want to be part of the journey? Join us! Mabwell Therapeutics, Inc. is a biotechnology company focusing on the discovery and development …See details»
Mabwell (Shanghai) Bioscience - Overview, News & Similar
May 12, 2024 Who is Mabwell (Shanghai) Bioscience. Mabwell, a values-based, R&D-driven biopharmaceutical company with more than 10 biologics pipelines focuses its efforts on five …See details»
Mabwell (Shanghai) Bioscience Co., Ltd. - Drug pipelines, Patents ...
Apr 1, 2025 Explore Mabwell (Shanghai) Bioscience Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 101 clinical trials, 51 news, and 20 literature, Disease …See details»
Mabwell Therapeutics - VentureRadar
Mabwell Therapeutics, Inc. is a privately-held biotechnology company focusing on the discovery and development of antibody and protein-based drugs for patients with rare diseases. We are …See details»
Mabwell Biotech - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Apr 29, 2020: Series A - …See details»
Mabwell Biotech - Contacts, Employees, Board Members
Mabwell Biotech has 1 current employee profile, Founder/CEO/ President Datao Liu. Datao Liu Founder/CEO/ President Browse By: Organizations, People, EventsSee details»
公司简介 - mabwell.com
迈威生物是一家全产业链布局的创新型生物制药公司，始终秉承“让创新从梦想变成现实”的愿景，践行“探索生命，惠及健康”的使命，通过源头创新，为患者提供疗效更好、可及性更强的生 …See details»
Capabilities - mabwell.com
Mabwell has established an advanced R&D system which covers target discovery, early discovery, druggability, preclinical, clinical research and manufacturing transformation. The …See details»
Mabwell to Present results of 6 studies at the 2025 American ...
Mar 26, 2025 Mabwell (688062.SH), an innovation-driven biopharmaceutical company with entire industry chain, announced that it will present results of 6 studies as poster presentation …See details»
Xin Du - Mabwell Therapeutics, Inc. | LinkedIn
Experience: Mabwell Therapeutics, Inc. · Location: San Diego County · 276 connections on LinkedIn. ... 2025 /PRNewswire/ — CovarsaDx®, a prominent Clinical Research Organization …See details»
Mabwell Bioscience Receives NMPA Approval for 9MW2821 …
Nov 15, 2024 Mabwell (Shanghai) Bioscience Co., Ltd (SHA: 688062), a China-based biopharmaceutical company, has announced that it has received approval from the National …See details»
Mabwell's cash flow is tightening step by step, and Jiangxi tycoons ...
Jan 19, 2025 The process of Mabwell's breakthrough in the Science and Technology Innovation Board was due to the ingenuity of the integration of the actual controller's resources, the …See details»
Mabwell to Present Clinical Data of 9MW2821 Combined with …
1 day ago Mabwell has 16 pipeline products in different stages based on a world-class and state-of-the-art R&D engine, including 12 novel drug candidates and 4 biosimilars. We focus …See details»
Mabwell Bioscience Files for IPO on Hong Kong Stock Exchange, …
Jan 7, 2025 Mabwell (Shanghai) Bioscience Co., Ltd. (SHA: 688062) has officially filed for an initial public offering (IPO) with the Hong Kong Stock Exchange. This move marks a significant …See details»
News - mabwell.com
Mabwell is an innovation-driven biopharmaceutical company with an entire industry chain of R&D, manufacturing, and commercialization. We provide more effective and accessible therapy and …See details»
"Burning money" is not only Mabwell's plan to go to Hong Kong …
Dec 20, 2024 Mabwell was listed on the A-share market two years ago at an issue price of RMB34.8 per share, raising net proceeds of approximately RMB3.3 billion at that time. As of …See details»